The Parkinson’s Unity Walk is an annual event held in New York’s Central Park to raise funds and awareness for Parkinson’s Disease. One hundred percent of funds raised by the Unity Walk go to research funded by six Parkinson’s disease foundations. Recipients of donations are the American Parkinson Disease Association, National Parkinson Foundation and Parkinson’s Disease Foundation (divisions of the Parkinson’s Foundation), The Michael J. Fox Foundation for Parkinson’s Research, The Parkinson Alliance, and The Parkinson’s Institute and Clinical Center. The 2017 Parkinson’s Unity Walk raised over $1.5 million for Parkinson’s disease research. One of the projects selected to receive funds from the Unity Walk is a research project supported by the Michael J Fox Foundation through their Therapeutic Pipeline Program, Alpha4Beta2 Nicotinic Agonist for Treatment of L-Dopa Refractory Gait and Balance Disorders in Parkinson Disease (University of Michigan PD researchers: Drs. Roger Albin and William Dauer, Udall Center of Excellence for Parkinson’s Disease Research). This research project hopes to identify a widely-used FDA-approved drug, varenicline, that may be useful in reducing falls in Parkinson’s patients.